Clinical management of the patient with pleural effusion

European Journal of Radiology

Volumn 34, Issue 2, 2000, Pages 76-86

  Ferrer, Jaume ^a   Roldán, Juan ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Clinical management; Pleural effusion; The main pleural diseases

Indexed keywords

BODY FLUIDS; DIAGNOSIS; PHYSIOLOGY; PULMONARY DISEASES;

PLEURAL EFFUSION;

RESPIRATORY THERAPY;

AMIODARONE; CLARITHROMYCIN; CORTICOSTEROID; DANTROLENE; DOPAMINE RECEPTOR STIMULATING AGENT; ERYTHROMYCIN; ETHAMBUTOL; ISONIAZID; METHOTREXATE; METHYSERGIDE; NITROFURANTOIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

COLLAGEN DISEASE; PLEURA DISEASE; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; TUBERCULOUS PLEURISY;

EID: 0034193025     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(00)00166-2     Document Type: Article

References (92)

1. Albertine K.H., Wiener-Kronish J.P., Roos P.J., Staub N.C. Structure, blood supply and lymphatic vessels of the sheep's visceral pleura. Am. J. Anat. 165:1982;277-294.
2. Wang N.S. Anatomy of the pleura. Clin. Chest Med. 19:1998;229-240.
3. Albertine K.H., Wiener-Kronish J.P., Staub N.C. The structure of the parietal pleura and its relationship to pleural liquid dynamics in sheep. Anat. Rec. 208:1984;401-409.
4. Fujimo S., Yokohama A., Kohno N., Hiwada K. Interleukin 6 as an autocrine growth factor for normal human pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 14:1996;508-515.
5. Anthony V.B., Hott J.W., Kunkel S.L., Godbey S.W., Burdick M.D., Strieter R.M. Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines. Am. J. Respir. Cell. Mol. Biol. 12:1995;581-588.
6. Philip Joet F., Alessi M.C., Philip-Joet C. et al. Fibrinolitic and inflammatory processes in pleural effusions. Eur. Respir. J. 8:1995;1352-1356.
7. Negrini D., Ballard S.T., Benoit J.N. Contribution of lymphatic myogenic activity and respiratory movements to pleural lymph flow. J. Appl. Physiol. 76:1994;2267-2274.
8. Gilmartin J.J., Wright A.J., Gibson G.J. Effects of pneumothorax or pleural effusion on pulmonary function. Thorax. 40:1985;60-65.
9. Agustí A.G.N., Cardús J., Roca J., Grau J.M., Xaubet A., Rodríguez-Roisín R. Ventilation-perfusion mismatch in patient with pleural effusion. Effects of thoracentesis. Am. J. Respir. Crit. Care Med. 156:1997;1205-1209.
10. Light R.W., Stansbury D.W., Brown S.E. Relationship between pleural pressures and changes in pulmonary function after therapeutic thoracentesis. Am. Rev. Respir. Dis. 133:1986;658-661.
11. Marel M., Arustova M., Stasny B., Light R.W. Incidence of pleural effusion in a well-defined region: epidemiologic study in central Bohemia. Chest. 104:1993;1486-1489.
12. Batungwanayo J., Taelman H., Allen S., Bogaerts J., Kagame A., Van de Perre P. Pleural effusion, tuberculosis and HIV infection in Kigali, Rwanda. AIDS. 7:1993;73-79.
13. Colt H.G., Brewer N., Barbur E. Evaluation of patient-related and procedure-related factors contributing to pneumothorax following thoracentesis. Chest. 116:1999;134-138.
14. Seneff M.G., Corwin R.W., Gold L.H., Irwin R.S. Complications associated with thoracentesis. Chest. 90:1986;97-100.
15. Light R.W., MacGregor M.I., Luchsinger P.C., Ball W.C. Pleural effusions: the diagnostic separation of transudates and exudates. Ann. Intern. Med. 77:1972;507-513.
16. Hamm H., Brohan U., Bohmer R., Missmahl H.P. Cholesterol in pleural effusions: a diagnostic aid. Chest. 92:1987;296-302.
17. Graham J.M., Mattox K.L., Beall A.C. Jr Penetrating trauma of the lung. J. Trauma. 19:1979;665-669.
18. Light R.W. Pleural Diseases. 1995;William and Wilkins, Baltimore.
19. Fairfax A.J., McNabb W.R., Spiro S.G. Chylothorax: a review of 18 cases. Thorax. 41:1986;880-885.
20. Halla J.T., Schronhenholer R.E., Volanakis J.E. Immune complexes and other laboratory features of pleural effusions. Ann. Intern. Med. 92:1980;748-752.
21. Good J.T., Khare V., Baethge B., Lang S., Wolf R.E., Douglas Campbell G.J. Antinuclear antibodies in pleural fluid. Chest. 106:1994;866-871.
22. Ferrer J., Villarino M.A., Encabo G. et al. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer. 86:1999;1488-1495.
23. Moriarty A.T., Wiersema L., Snyder W., Kotylo P.K., McCloskey D.W. Immunophenotyping of cytologic specimens by flow cytometry. Diagn. Cytopathol. 9:1993;252-258.
24. Korsgaard R. Chromosome analysis of malignant human effusions in vivo. Scand. J. Respir. Dis. 105((Suppl.)):1979;1-100.
25. Poe R.E., Israel R.H., Utell M.J., Hall W.J., Greenblatt D.W., Kallay M.C. Sensitivity, specificity, and predictive values of closed pleural biopsy. Arch. Intern. Med. 144:1984;325-328.
26. Boutin C., Viallat J.R., Cargnino P., Farisse P. Thoracoscopy in malignant pleural effusions. Am. J. Crit. Care Med. 124:1981;588-592.
27. Menzies R., Carbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann. Intern. Med. 114:1991;271-276.
28. Chang S.-C., Perng R.P. The role of fiberoptic bronchoscopy in evaluating the causes of pleural effusions. Arch. Intern. Med. 149:1989;855-857.
29. Poe R.H., Levy P.C., Israel R.H., Ortiz C.R., ally M.C. Use of fiberoptic bronchoscopy in the diagnosis of bronchogenic carcinoma. A study in patients with idiopathic pleural effusions. Chest. 105:1994;1663-1667.
30. Ferrer J., Muñoz X., Orriols R., Light R.W., Morell F. Evolution of idiopathic pleural effusion. A prospective, long-term follow-up study. Chest. 109:1996;1508-1513.
31. Light R.W., Girard W.M., Jenkinson S.G., George R.B. Parapneumonic effusions. Am. J. Med. 69:1980;507-511.
32. Taryle D.A., Potts D.E., Sahn S.A. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. Chest. 74:1978;170-173.
33. Alfageme I., Muñoz F., Peña N., Umbría S. Empyema of the thorax in adults. Etiology, microbiologic findings, and management. Chest. 103:1993;839-843.
34. Brook I., Frazier E.H. Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. Chest. 103:1993;1502-1507.
35. Bartlett J.G. Bacterial infections of the pleural space. Semin. Respir. Infect. 3:1988;308-321.
36. Bouros D., Schiza S., Tzanakis N., Chalkiadakis G., Drositis J., Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am. J. Respir. Crit. Care Med. 159:1999;37-42.
37. Lim T.K., Chin N.K. Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. Eur. Respir. J. 13:1999;514-518.
38. Fine N.L., Smith L.R., Sheedy P.F. Frequency of pleural effusions in mycoplasma and viral pneumonias. New Engl. J. Med. 283:1970;790-793.
39. Vidal R., De Gracia J., Ruiz J., Fité E., Monsó E., Martín N. Estudio controlado de 637 pacientes con tuberculosis: diagnóstico y resultados terapéuticos con esquemas de 6 y 9 meses. Med. Clin. (Barc.). 87:1986;368-370.
40. Epstein D.M., Kline L.R., Albelda S.M., Miller W.T. Tuberculous pleural effusions. Chest. 91:1987;106-109.
41. Ferrer J. Pleural tuberculosis. Eur. Respir. J. 10:1997;942-947.
42. Richter C., Perenboom R., Mtoni I. et al. Clinical features of HIV-seropositive and HIV-seronegative patients with tuberculous pleural effusion in Dar-es-Salaam, Tanzania. Chest. 106:1994;1471-1475.
43. Light R.W., Erozan Y.S., Ball W.C. Cells in pleural fluid: their value in differential diagnosis. Arch. Intern. Med. 132:1973;854-860.
44. Escudero Bueno C., Clemente G., Castro B.C. et al. Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope's needle. Arch. Intern. Med. 150:1990;1190-1194.
45. Berger H.W., Mejía E. Tuberculous pleurisy. Chest. 63:1973;88-92.
46. Ocaña Y., Martínez-Vázquez J.M., Segura R.M., Fernández de Sevilla T., Capdevila J.A. Adenosine deaminase in pleural fluids: test for diagnosis of tuberculous pleural effusion. Chest. 84:1983;51-53.
47. Valdés L., San José E., Alvarez D. et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozime, interferon gamma. Chest. 103:1993;458-465.
48. Hsu W.H., Chiang C.D., Huang P.L. Diagnostic value of pleural adenosine deaminase in tuberculous effusions of immunocompromised hosts. J. Formos. Med. Assoc. 92:1993;668-670.
49. Petterson T., Ojala K., Weber T.H. Adenosine deaminase in pleural fluids. Test for diagnosis of tuberculous pleural effusions. Acta Med. Scand. 215:1984;299-304.
50. Orriols R., Muñoz X., Drobnic M.E., Ferrer J., Morell F. High adenosine deaminase activity in pleural effusion due to psittacosis. Chest. 101:1992;881-882.
51. Ungerer J.P.J., Ooshuizen H.M., Retief J.H., Bissbort S.H. Significance of adenosine deaminase activity and its isoenzymes in tuberculous effusions. Chest. 106:1994;33-37.
52. Valdés L., Alvarez D., San José E. et al. Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis. Thorax. 50:1995;600-603.
53. Kuwano K., Minamide W., Kusunoki S. et al. Evaluation of nested polymerase chain reaction for detecting mycobacterial DNA in pleural fluid. Kansenshogaku Azsshi. 69:1995;175-180.
54. Querol J.M., Minguez J., Garcia-Sanchez E., Farga M.A., Gimeno C., Garcia de Lomas J. Rapid diagnosis of pleural tuberculosis by polymerase chain reaction. Am. J. Respir. Crit. Care Med. 152:1995;1977-1981.
55. Bass J.B., Farer L.S., Hopewell P.C. et al. Treatment of tuberculosis and tuberculous infection in adults and children. Am. J. Respir. Crit. Care Med. 149:1994;1359-1374.
56. Lee C.H., Wang W.J., Lan R.S., Tsai Y.H., Chiang Y.C. Corticosteroids in the treatment of tuberculous pleurisy: a double-blind, placebo-controlled, randomized study. Chest. 94:1988;1256-1259.
57. Galarza Y., Cañete C., Granados A., Estopá R., Manresa F. Randomized trial of corticosteroids in the treatment of tuberculous pleurisy. Thorax. 50:1995;1305-1307.
58. Marel M., Stastny B., Melinova L., Svandova E., Light R.W. Diagnosis of pleural effusions. Experience with clinical studies. Chest. 107:1995;1598-1603.
59. Chernow B., Sahn S.A. Carcinomatous involvement of the pleura. An analysis of 96 patients. Am. J. Med. 63:1977;695-702.
60. Meyer P.C. Metastatic carcinoma of the pleura. Thorax. 21:1966;437-443.
61. Dogamala W., Emeson E., Kass L.G. Distribution of T-lymphocytes and B-lymphocytes in peripheral blood and effusions in patients with cancer. J. Natl. Cancer Inst. 61:1978;295-300.
62. Prakash U.R.S., Reiman H.M. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin. Proc. 60:1985;158-164.
63. Salyer W.R., Eggleston J.C., Erozan Y.S. Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neplasm involving the pleura. Chest. 67:1975;536-539.
64. Fentiman I.S., Millis R., Sexton S., Hayward J.L. Pleural effusion in breast cancer: a review of 105 cases. Cancer. 47:1981;2087-2092.
65. Sahn S.A., Good J.T. Jr Pleural fluid pH in malignant effusions: diagnostic, prognostic and therapeutic implications. Ann. Intern. Med. 108:1988;345-349.
66. Weick J.K., Kiely J.M., Harrison E.G. Jr et al. Pleural effusion in lymphoma. Cancer. 31:1973;848-853.
67. Livingston R.B., McCracken J.D., Trauth C.J., Chen T. Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. Chest. 81:1982;208-211.
68. Walker-Rennard P.B., Vaughan L.M., Sahn S.A. Chemical pleurodesis for malignant pleural effusions. Ann. Intern. Med. 120:1994;56-64.
69. Aelony Y., King R., Boutin C. Thoracoscopy talc poudrage for chronic recurrent pleural effusions. Ann. Intern. Med. 115:1991;778-782.
70. Kennedy L., Rusch V.W., Strange C., Ginsberg R.J., Sahn S.A. Pleurodesis using talc slurry. Chest. 106:1994;342-346.
71. Oels H.C., Harrison E.G. Jr, Carr D.T., Bernatz P.E. Diffuse malignant mesothelioma of the pleura: a review of 73 cases. Chest. 60:1971;564-570.
72. Antman K.H. Clinical presentation and natural history of benign and malignant mesothelioma. Semin. Oncol. 8:1981;313-320.
73. Wagner J.C., Berry G., Timbrell V. Mesothelioma in rats after inoculation with asbestos and other materials. Br. J. Cancer. 28:1973;173-185.
74. Churg A. Asbestos-related disease in the workplace and the environment: controversial issues. Monogr. Pathol. 36:1993;52-57.
75. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br. J. Dis. Chest. 77:1983;321-343.
76. Boutin C., Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 patients. Part 1: diagnosis. Cancer. 72:1993;389-393.
77. Boutin C., Rey F., Viallat J.R. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. Cancer. 108:1995;754-758.
78. Sugarbeker D.J., Heher E.C., Lee T.H. et al. Extrapleural pneumonectomy, chemotherapy and radiotherapy in the treatment of diffuse malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 102:1991;10-15.
79. Sugarbaker DJ, García JP, Richards WG et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients. Ann Surg. 244:1996;288-296.
80. Astoul P.H., Viallat J.R., Laurent J.C., Brandely M., Boutin C. Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion. Chest. 103:1993;209-213.
81. Walker W.C., Wright V. Rheumatoid pleuritis. Ann. Rheum. Dis. 26:1967;467-473.
82. Pertschuk L.P., Moccia L.F., Rosen Y. et al. Pleuropulmonary complications in systemic lupus erythematosus. Immunofluorescence and light microscopic study. Am. J. Clin. Pathol. 68:1977;553.
83. Good J.T. Jr, King T.E., Antony V.B., Sahn S.A. Lupus pleuritis: clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest. 84:1983;714-718.
84. Winslow W.A., Ploss L.N., Loitman B. Pleuritis in systemic lupus erythematosus: its importance as an early manifestation in diagnosis. Ann. Intern. Med. 49:1958;70-88.
85. Kaine J.L. Refractory massive pleural effusion in systemic lupus erythematosus. Ann. Rheum. Dis. 47:1988;1031-1032.
86. Shaw R.A., Schonfeld S.A., Whitcomb M.E. A perplexing case of hilar adenopathy. Chest. 80:1981;736-740.
87. Strimlan C.V., Rosenow E.C., Divertie M.G., Harrison E.G. Pulmonary manifestations of Sjögren syndrome. Chest. 70:1976;354-361.
88. Morelock S.Y., Sahn S.A. Drugs and the pleura. Chest. 116:1999;212-221.
89. Epler G.R., McLoud T.C., Gaensler E.A. Prevalence and incidence of benign asbestos pleural effusion in a working population. J. Am. Med. Assoc. 247:1982;617-622.
90. Hillerdal G., Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur. J. Respir. Dis. 71:1987;113-121.
91. Berger H.W., Rammohan G., Neff M.S., Buhain W.J. Uremic pleural effusion: a study in 14 patients on chronic dialysis. Ann. Intern. Med. 82:1975;362-364.
92. Miller R.H., Horneffer P.J., Gardner T.J., Rykiel M.F., Pearson T.A. The epidemiology of the postpericardiotomy syndrome: a common complication of cardiac surgery. Am. Heart J. 116:1988;1323-1329.